Javier Arístegui

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

Javier Arístegui, E. Bernaola, Itziar Pocheville et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2007 · 70 citations

Vaccinology, Vaccine Safety, Vaccination +7

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age

Javier Arístegui, Rafael Dal−Ré, Elisa Garrote et al. · Vaccine · 1998 · 28 citations

Vaccination, Vaccine Safety, Vaccine Development +10

A short in-frame deletion in NTRK1 tyrosine kinase domain caused by a novel splice site mutation in a patient with congenital insensitivity to pain with anhidrosis

Esther Sarasola, José Antonio Rodríguez, Elisa Garrote et al. · BMC Medical Genetics · 2011 · 20 citations · Full text

A public-professional web-bridge for vaccines and vaccination: User concerns about vaccine safety

Alberto L. García‐Basteiro, María-José Álvarez-Pasquín, Guillermo Mena et al. · Vaccine · 2011 · 11 citations

Vaccination, Vaccine Safety, Preventive Medicine +8

[Consensus document on vaccination against influenza in health care workers].

JJ Picazo, L M Alonso, Javier Arístegui et al. · PubMed · 2012 · 10 citations